Related Experiment Videos
Update on Heparin Anticoagulation During Coronary Intervention
1Cardiology Division, New Mexico Heart Institute, 1001 Coal Road, SE, Albuquerque, NM 87106, USA.
Current Interventional Cardiology Reports
|November 30, 2000
Abstract:
Although the equipment, techniques, and adjunctive pharmacologic agents used during coronary angioplasty have evolved dramatically over the past 20 years, unfractionated heparin remains a standard component of the procedure. This article reviews recent data and current concepts regarding the use, importance, and proper dosing of heparin during percutaneous coronary intervention, especially when concomitant platelet glycoprotein IIb/IIIa receptor antagonist therapy is used.